Endpoints News 19 may 2026 Relay's PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
Mettler Toledo 19 may 2026 Mettler-Toledo International (NYSE:MTD) Surfaces as a Quality Investing Candidate on Caviar Cruise Screen - ChartMill
10x Genomics News 19 may 2026 Understanding plate, droplet and microwell approaches in single-cell RNA sequencing - News-Medical
Illumina 19 may 2026 SomaLogic Inc stock (US82489T1043): Illumina takeover reshapes proteomics story - AD HOC NEWS
Lonza News 19 may 2026 Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG - Yahoo Finance Singapore
Boston Scientific 19 may 2026 FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints - www.bostonscientific.com
FierceBiotech 19 may 2026 Relay ‘full steam ahead’ on PI3K inhibitor fueled by first phase 2 data in blood vessel disorder
Revvity 19 may 2026 Revvity (RVTY) Is Down 5.0% After Raising 2026 Outlook And Securing FDA Assay Clearance - Sahm
Abbott 19 may 2026 Abbott Laboratories stock (US0028241000): steady momentum after latest earnings and diabetes tech pu - AD HOC NEWS
10x Genomics Blog 19 may 2026 10X Genomics’ SWOT analysis: stock faces profitability test - Investing.com
Vertex 19 may 2026 Vertex Pharma stock (US92532F1003): cystic fibrosis leader after solid quarterly results - AD HOC NEWS